971 INHIBITORY EFFECT OF D1-LIKE DOPAMINE RECEPTORS ON NEUROPEPTIDE Y-INDUCED PROLIFERATION IN VASCULAR SMOOTH MUSCLE CELLS

Yongqiao Zhou,Yu Han,Jian Yang,Li Liu,Wei Wang,Lin Zhou,Xuerui Tan,Chunyu Zeng

DOI: https://doi.org/10.1097/01.hjh.0000420889.76287.fe

IF: 4.9

2012-01-01

Journal of Hypertension

Abstract:Background: Proliferation of VSMCs is thought to play key roles in the development of atherosclerotic lesions. The neuropeptide Y (NPY) has been shown to stimulate proliferation on vascular smooth muscle cells (VSMCs). NPY, norepinephrine and dopamine are all the sympathetic transmitters. Our previous study found that in the presence of dopamine receptor, the α1-adrenergic receptor-mediated VSMC proliferation is reduced. We hypothesize that activation of D1-like receptor might also inhibit the NPY-mediated VSMC proliferation. Methods And Results: In present study, we found that NPY, mainly via Y1 receptor, increased VSMC proliferation, determined by [3H]-thymidine incorporation, in a concentration (10−11-10−8M)-dependent manner. In the presence of fenoldopam (10−12-10−5M), a D1-like dopamine receptor agonist, the stimulatory effect of NPY on VSMC proliferation was reduced. The inhibitory effect of fenoldopam was via D1-like receptor, because in the presence of D1-like receptor antagonist, SCH23390 (10−8M), the above-mentioned effect of fenoldopam was blocked. Moreover, the inhibitory effect of fenoldopam on NPY-mediated VSMC proliferation was blocked in the presence of PKA inhibitor, PKA inhibitor 14–22 (10−6M). PKA stimulator, PKA activator 8-(4-chlorophenylthio) adenosine-3,5-cyclic monophosphorothioate, Sp-isomer sodium salt (10−6M) could mimick the stimulatory effect of fenoldopam. Conclusions: Our researches indicated that the inhibitory effect of D1-like receptors on NPY-mediated VSMC proliferation may play an important role on regulation of blood pressure or prevention of atherosclerosis.